#Sustainability #healthcare #Haier Biomedical

Haier Biomedical Publishes 2025 Sustainability Report

Haier Biomedical, known for its leadership in life sciences and medical solutions, has unveiled its 2025 Sustainability Report. This document outlines the strides made towards achieving environmental, social, and governance goals, emphasizing a commitment to safer and more environmentally friendly healthcare and life sciences.

Within its sustainability strategy titled LIFE—standing for Leadership, Integrity, Future, and Ecosystem—Haier Biomedical is dedicated to supporting the 17 United Nations Sustainable Development Goals (SDGs). The company aims to enhance public health initiatives worldwide by focusing on local service networks and advancing important scientific research. By adopting innovative low-carbon solutions, it seeks to drive sustainable development across various industrial chains.

Chairwoman Tan Lixia outlined the company’s growth trajectory, stating, "In 2025, we achieved three strategic advancements: transitioning from products to scenarios, expanding from China to the global market, and evolving from a singular industry to a comprehensive ecosystem platform." The dedication to green innovation within healthcare remains foundational under the company’s LIFE framework.

Furthermore, Haier Biomedical prioritizes research and development (R&D), establishing a well-structured management system that enhances resource allocation and fosters technological breakthroughs. Impressively, R&D personnel constitute 28.56% of the entire workforce, with the total investment in R&D reaching 323 million yuan (approximately USD 47.25 million). The year saw a remarkable 50% increase in new invention patents, leading to a portfolio where 73% are non-storage patents. The company also boasts 428 software copyrights and an impressive array of contributions to science and technology standards.

Recently, Haier Biomedical has integrated artificial intelligence (AI) into its product development efforts, launching